GaN Devices raised €30M in a Series C round in Feb 2025. The company is based in Cambridge, UK. Investors in the round: BGF, British Patient Capital, Cambridge Innovation Capital and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
